<DOC>
	<DOCNO>NCT00210912</DOCNO>
	<brief_summary>The purpose study assess safety effectiveness topiramate compare placebo prevention headache patient chronic migraine . Topiramate approve prevent migraine headache well treatment epilepsy .</brief_summary>
	<brief_title>A Study Effectiveness Safety Topiramate Versus Placebo Preventing Chronic Migraine Headaches</brief_title>
	<detailed_description>Migraine headache disable interfere work person 's quality life . Preventing headache start best option . Topiramate , anti-seizure medication , show help prevent migraine headache occur . This multicenter , randomize , double-blind , placebo-controlled , parallel group study patient chronic migraine . The Pretreatment Phase study last 56 day consist 2 study period : Screening/Washout Period ( Day -56 Day -29 ) Prospective Baseline Period ( 28 day ) . Medications use prevent migraine stop 14 28 day prior Prospective Baseline Period rest study . The Prospective Baseline Period begin study Day -28 ( Visit 2 ) , patient maintain daily headache record period . Those move forward study must least 15 headache day period , half need migraine headache day . Patients finish Prospective Baseline Period , require rate headache , continue meet remainder entry criterion randomize ( like toss coin ) 1 2 treatment group : topiramate 100 milligram per day placebo . The Double-Blind Phase last 16 week . During first 4 week , patient titrate topiramate dose 100 milligram per day maximum tolerate dose , whichever less . The next 12 week maintenance phase continue take dose take end 4-week titration period . The primary hypothesis study mean decrease number migraine/migrainous headache day per month great topiramate group placebo group topiramate generally well-tolerated . Topiramate 25 milligram tablet , 2 tablet mouth twice daily , maximum tolerate dose , whichever less , 12 week , 2 placebo tablet twice daily 12 week</detailed_description>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Topiramate</mesh_term>
	<criteria>Diagnosis chronic migraine &gt; =15 headache day per month past 30 day &gt; = 15 headache day , half need migraine headache prospective baseline period MIDAS test score &gt; = 11 Visit 1 In generally good health If female , use birth control No abnormalities neurological examination Failed &gt; 2 adequate trial migraine prevention medication Failed topiramate due lack effectiveness adverse event Daily headache severe intensity past 30 day Cluster , basilar , ophthalmoplegic , hemiplegic migraine Migraines start age 50 Other pain great migraine pain Use drug treat migraine &gt; 4 day per week past month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>prevention</keyword>
	<keyword>Migraine</keyword>
	<keyword>chronic</keyword>
	<keyword>headache</keyword>
</DOC>